POULTON STUART (EVP, Chief Development Officer) sold 0.4% of their position (378.00 shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $3.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2026ACC: 0001193125-26-059332
Officer· EVP, Chief Development Officer
Since Mar 2026
-378.00
Net shares
Net seller
$3.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
378.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−378.00
Price / share
$8.63
Trade value
$3.26K
% of position
0.4%
2/17/2026
99.81K→99.43K
Total
Net shares
−378.00
Net value
-$3.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | S · Sale | −378.00 | $8.63 | $3.26K | 0.4% | 99.81K | 99.43K |
| Total | −378.00 | -$3.26K | ||||||
Derivative Transactions0
No derivative transactions reported